research

If Anyone Doubts We Are In A Stock Market Bubble, Show Them …

Submitted by Michael Snyder via The Economic Collapse blog,The higher financial markets rise, the harder they fall. By any objective measurement, the stock market is currently well into bubble territory. Anyone should be able to see this – all you have to do is look at the charts. Sadly, most of us never seem to learn from history. Most of […]

If Anyone Doubts That We Are In A Stock Market Bubble, Show …

By Michael Snyder, on April 1st, 2015The higher financial markets rise, the harder they fall.  By any objective measurement, the stock market is currently well into bubble territory.  Anyone should be able to see this – all you have to do is look at the charts.  Sadly, most of us never seem to learn from history.  Most of us […]

An ETF That can Quiet Biotech Boo Birds

Since reaching all-time highs on March 19, the three largest biotech exchange traded funds are off 4.4% with the SPDR S&P Biotech ETF (XBI) ranking as the worst offender of the trio with a loss of 5.7%.XBI’s recent struggles illustrate the ETF’s risk/reward proposition. As an equal-weight ETF, the $2.1 billion XBI is dependent on the largest biotech stocks, such […]

Credit Suisse on Biotech’s Nirvana Phase

Credit Suisse on Biotech’s Nirvana Phase
Posted March 27, 2015 by Joshua M Brown
There’s a really interesting piece of research out from Credit Suisse in which Ravi Mehrotra & Co lay out an “It’s different this time” thesis that seeks to explain why the huge rally in biotech stocks is justified and possibly not over yet.
They note that there are indeed […]

Biotech stocks are looking crowded, expert says

The stock has even more upside from where it was trading Friday, around $475 per share, Yaron Werber, senior biotech analyst at Citi Investment Research, told “Power Lunch.” As the Alzheimer’s drug likely will not reach the market for years, it is important to Biogen’s long-term prospects, he said.When looking at valuations, investors need to consider that low interest rates […]

Biotech value getting tough to find: Expert

The stock has even more upside from where it was trading Friday, around $475 per share, Yaron Werber, senior biotech analyst at Citi Investment Research, told “Power Lunch.” As the Alzheimer’s drug likely will not reach the market for years, it is important to Biogen’s long-term prospects, he said.When looking at valuations, investors need to consider that low interest rates […]

Don't Be Seduced By The Siren Song Of The Stock Market | The …

I recently wrote that, “the single greatest mistake investors make is to extrapolate recent history out into the future.” As an example of how dangerous this natural tendency is, I shared a bit of Warren Buffett’s warning from late 1999 in which he wrote that the amazing returns from the stock market during that period had led to investor expectations rising […]

The Daily Startup: Allergen Research Raises $80M to Fight Peanut Allergies

Art by Mike LucasAllergen Research has raised $80 million to help tackle the problem of peanut allergies, Brian Gormley reports for Dow Jones VentureWire. The company is developing a  product that desensitizes patients so that accidental exposure to peanuts doesn’t cause a severe allergic response. Peanut allergy is one of the most common of food allergies, which affect 5% of children and 4% […]

Like Your Job? The Stock Market Will Probably Like Your Company …

By
Josh Zumbrun

[email protected]
Biography

CONNECT

[email protected]
Biography

Companies trying to decide whether it’s worthwhile to create a friendly workplace could do well to consider this: Companies that employees report to be a good place to work have significantly outperformed the S&P 500 over the past six years.The data comes from Glassdoor Inc., an online job and company information website, which solicits employees to post anonymous reviews of […]

7 Signs That A Stock Market Peak Is Happening Right Now

By Michael Snyder, on March 9th, 2015Is this the end of the last great run for the U.S. stock market?  Are we witnessing classic “peaking behavior” that is similar to what occurred just before other major stock market crashes?  Throughout 2014 and for the early stages of 2015, stocks have been on quite a tear.  Even though the overall […]